|
|
Volumn 12, Issue 8 I, 1999, Pages 797-805
|
|
Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension
a
|
|
Author keywords
Combination therapy; Hydrochlorothiazide; Hypertension; Irbesartan; Randomized controlled trial
|
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
HYDROCHLOROTHIAZIDE;
IRBESARTAN;
PLACEBO;
THIAZIDE DIURETIC AGENT;
ADULT;
ANTIHYPERTENSIVE THERAPY;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIURETIC THERAPY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
FEMALE;
HEADACHE;
HUMAN;
HYPERTENSION;
MAJOR CLINICAL STUDY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
VERTIGO;
ANTIHYPERTENSIVE AGENTS;
BIPHENYL COMPOUNDS;
BLOOD PRESSURE;
DIURETICS;
DOUBLE-BLIND METHOD;
DRUG COMBINATIONS;
FEMALE;
HEART RATE;
HUMANS;
HYDROCHLOROTHIAZIDE;
HYPERTENSION;
MALE;
MIDDLE AGED;
POTASSIUM;
SAMPLE SIZE;
SINGLE-BLIND METHOD;
SODIUM CHLORIDE SYMPORTER INHIBITORS;
TETRAZOLES;
URIC ACID;
|
|
EID: 0032869894
PISSN: 08957061
EISSN: None
Source Type: Journal
DOI: 10.1016/S0895-7061(99)00053-9 Document Type: Article |
|
Times cited : (111)
|
|
References (23)
|
